Source: StreetInsider

Press Release: NantHealth : NantHealth Continues Global Expansion of GPS Cancer by Bringing Advanced Genomic Profiling to Patients in Mexico

NantHealth, Inc. (Nasdaq: NH), a leading next-generation, evidence-based, personalized healthcare company, today announced that GPS Cancer, a molecular test that helps guide cancer treatment strategies including choice of standard chemotherapy for oncologists, is now covered by Sistemas Medicos Nacionales, S.A. de C.V. (SIMNSA), a comprehensive healthcare service plan that provides quality care for patients in the cities of Tijuana, Tecate and Mexicali. With the availability and coverage of GPS Cancer, oncologists can now provide patients in northern Mexico with a more precise, personalized approach to their cancer care.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Patrick Soon-Shiong's photo - Chairman & CEO of NantHealth

Chairman & CEO

Patrick Soon-Shiong

CEO Approval Rating

89/100

NantHealth is a cloud-based medical Information Technology platform that enables medical professionals to share and deliver healthcare information. Read more